{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:50:37Z","timestamp":1789537837643,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T00:00:00Z","timestamp":1593216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T00:00:00Z","timestamp":1593216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2013_A182"],"award-info":[{"award-number":["2013_A182"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2013_A182"],"award-info":[{"award-number":["2013_A182"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2013_A182"],"award-info":[{"award-number":["2013_A182"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["694913"],"award-info":[{"award-number":["694913"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Context<\/jats:title>\n                <jats:p>Primary aldosteronism (PA) is the most frequent form of endocrine hypertension. Besides its deleterious impact on cardiovascular target organ damage, PA is considered to cause osteoporosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Patients and methods<\/jats:title>\n                <jats:p>We assessed bone turnover in a subset of 36 postmenopausal women with PA. 18 patients had unilateral PA and were treated by adrenalectomy, whereas 18 patients had bilateral PA and received mineralocorticoid receptor antagonist (MRA) therapy respectively. 18 age- and BMI-matched females served as controls. To estimate bone remodeling, we measured the bone turnover markers intact procollagen 1 N-terminal propeptide, bone alkaline phosphatase, osteocalcin and tartrate resistant acid phosphatase 5b in plasma by chemiluminescent immunoassays at time of diagnosis and one year after initiation of treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Study design<\/jats:title>\n                <jats:p>Observational longitudinal cohort study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Setting<\/jats:title>\n                <jats:p>Tertiary care hospital.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Compared with controls, patients with PA had mildly elevated osteocalcin at baseline (<jats:italic>p<\/jats:italic>\u2009=\u20090.013), while the other bone markers were comparable between both groups. There were no differences between the unilateral and the bilateral PA subgroup. One year after initiation of MRA treatment with spironolactone bone resorption and bone formation markers had significantly decreased in patients with bilateral PA. In contrast, patients adrenalectomized because of unilateral PA showed no significant change of bone turnover markers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study shows that aldosterone excess in postmenopausal women with PA is not associated with a relevant increase of bone turnover markers at baseline. However, we observed a significant decrease of bone markers in patients treated with spironolactone, but not in patients treated by adrenalectomy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12020-020-02348-8","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T14:02:35Z","timestamp":1593266555000},"page":"625-633","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Spironolactone reduces biochemical markers of bone turnover in postmenopausal women with primary aldosteronism"],"prefix":"10.1007","volume":"69","author":[{"given":"Christian","family":"Adolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah T.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmina T.","family":"Fuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Hahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"K\u00fcnzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Handgriff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Sturm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bidlingmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,27]]},"reference":[{"issue":"14","key":"2348_CR1","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"S. Monticone, J. Burrello, D. Tizzani, C. Bertello, A. Viola, F. Buffolo, L. Gabetti, G. Mengozzi, T.A. Williams, F. Rabbia, F. Veglio, P. Mulatero, Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J. Am. Coll. Cardiol. 69(14), 1811\u20131820 (2017). https:\/\/doi.org\/10.1016\/j.jacc.2017.01.052","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"2348_CR2","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"G.P. Rossi, G. Bernini, C. Caliumi, G. Desideri, B. Fabris, C. Ferri, C. Ganzaroli, G. Giacchetti, C. Letizia, M. Maccario, F. Mallamaci, M. Mannelli, M.J. Mattarello, A. Moretti, G. Palumbo, G. Parenti, E. Porteri, A. Semplicini, D. Rizzoni, E. Rossi, M. Boscaro, A.C. Pessina, F. Mantero, P.S. Investigators, A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J. Am. Coll. Cardiol. 48(11), 2293\u20132300 (2006). https:\/\/doi.org\/10.1016\/j.jacc.2006.07.059","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"2348_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"S. Monticone, F. D\u2019Ascenzo, C. Moretti, T.A. Williams, F. Veglio, F. Gaita, P. Mulatero, Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 6(1), 41\u201350 (2018). https:\/\/doi.org\/10.1016\/S2213-8587(17)30319-4","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"5","key":"2348_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1530\/EJE-17-0417","volume":"177","author":"AS Salcuni","year":"2017","unstructured":"A.S. Salcuni, V. Carnevale, C. Battista, S. Palmieri, C. Eller-Vainicher, V. Guarnieri, F. Pugliese, G. Guglielmi, G. Desina, S. Minisola, I. Chiodini, A. Scillitani, Primary aldosteronism as a cause of secondary osteoporosis. Eur. J. Endocrinol. 177(5), 431\u2013437 (2017). https:\/\/doi.org\/10.1530\/EJE-17-0417","journal-title":"Eur. J. Endocrinol."},{"issue":"13","key":"2348_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1055\/s-0035-1565208","volume":"47","author":"H Remde","year":"2015","unstructured":"H. Remde, G. Hanslik, N. Rayes, M. Quinkler, Glucose metabolism in primary aldosteronism. Horm. Metab. Res. 47(13), 987\u2013993 (2015). https:\/\/doi.org\/10.1055\/s-0035-1565208","journal-title":"Horm. Metab. Res."},{"issue":"9","key":"2348_CR6","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.1210\/jc.2005-0681","volume":"90","author":"M Stowasser","year":"2005","unstructured":"M. Stowasser, J. Sharman, R. Leano, R.D. Gordon, G. Ward, D. Cowley, T.H. Marwick, Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J. Clin. Endocrinol. Metab. 90(9), 5070\u20135076 (2005). https:\/\/doi.org\/10.1210\/jc.2005-0681","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"2348_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jacc.2005.03.055","volume":"46","author":"PH Law","year":"2005","unstructured":"P.H. Law, Y. Sun, S.K. Bhattacharya, V.S. Chhokar, K.T. Weber, Diuretics and bone loss in rats with aldosteronism. J. Am. Coll. Cardiol. 46(1), 142\u2013146 (2005). https:\/\/doi.org\/10.1016\/j.jacc.2005.03.055","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"2348_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000441-200507000-00001","volume":"330","author":"AL Runyan","year":"2005","unstructured":"A.L. Runyan, V.S. Chhokar, Y. Sun, S.K. Bhattacharya, J.W. Runyan, K.T. Weber, Bone loss in rats with aldosteronism. Am. J. Med Sci. 330(1), 1\u20137 (2005). https:\/\/doi.org\/10.1097\/00000441-200507000-00001","journal-title":"Am. J. Med Sci."},{"issue":"10","key":"2348_CR9","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1002\/jbmr.1660","volume":"27","author":"AS Salcuni","year":"2012","unstructured":"A.S. Salcuni, S. Palmieri, V. Carnevale, V. Morelli, C. Battista, V. Guarnieri, G. Guglielmi, G. Desina, C. Eller-Vainicher, P. Beck-Peccoz, A. Scillitani, I. Chiodini, Bone involvement in aldosteronism. J. Bone Min. Res 27(10), 2217\u20132222 (2012). https:\/\/doi.org\/10.1002\/jbmr.1660","journal-title":"J. Bone Min. Res"},{"issue":"4","key":"2348_CR10","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1210\/jc.2016-3206","volume":"102","author":"M Notsu","year":"2017","unstructured":"M. Notsu, M. Yamauchi, M. Yamamoto, K. Nawata, T. Sugimoto, Primary aldosteronism as a risk factor for vertebral fracture. J. Clin. Endocrinol. Metab. 102(4), 1237\u20131243 (2017). https:\/\/doi.org\/10.1210\/jc.2016-3206","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"2348_CR11","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/jbmr.3033","volume":"32","author":"VC Wu","year":"2017","unstructured":"V.C. Wu, C.H. Chang, C.Y. Wang, Y.H. Lin, T.W. Kao, P.C. Lin, T.S. Chu, Y.S. Chang, L. Chen, K.D. Wu, S.J. Chueh, Risk of fracture in primary aldosteronism: a population-based cohort study. J. Bone Min. Res. 32(4), 743\u2013752 (2017). https:\/\/doi.org\/10.1002\/jbmr.3033","journal-title":"J. Bone Min. Res."},{"issue":"2","key":"2348_CR12","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1210\/jc.2017-02043","volume":"103","author":"BJ Kim","year":"2018","unstructured":"B.J. Kim, M.K. Kwak, S.H. Ahn, H. Kim, S.H. Lee, J.M. Koh, Lower trabecular bone score in patients with primary aldosteronism: human skeletal deterioration by aldosterone excess. J. Clin. Endocrinol. Metab. 103(2), 615\u2013621 (2018). https:\/\/doi.org\/10.1210\/jc.2017-02043","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2348_CR13","doi-asserted-by":"publisher","unstructured":"C.H. Wu, Y.F. Chang, C.H. Chen, E.M. Lewiecki, C. Wuster, I. Reid, K.S. Tsai, T. Matsumoto, L.B. Mercado-Asis, D.C. Chan, J.S. Hwang, C.L. Cheung, K. Saag, J.K. Lee, S.T. Tu, W. Xia, W. Yu, Y.S. Chung, P. Ebeling, A. Mithal, S.L. Ferrari, C. Cooper, G.T. Lin, R.S. Yang, Consensus statement on the use of bone turnover markers for short-term monitoring of osteoporosis treatment in the Asia-Pacific Region. J. Clin. Densitom. (2019). https:\/\/doi.org\/10.1016\/j.jocd.2019.03.004","DOI":"10.1016\/j.jocd.2019.03.004"},{"issue":"11","key":"2348_CR14","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1007\/s00198-013-2399-1","volume":"24","author":"L Ceccoli","year":"2013","unstructured":"L. Ceccoli, V. Ronconi, L. Giovannini, M. Marcheggiani, F. Turchi, M. Boscaro, G. Giacchetti, Bone health and aldosterone excess. Osteoporos. Int. 24(11), 2801\u20132807 (2013). https:\/\/doi.org\/10.1007\/s00198-013-2399-1","journal-title":"Osteoporos. Int"},{"issue":"2","key":"2348_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.23736\/S0391-1977.16.02553-0","volume":"43","author":"HH Loh","year":"2018","unstructured":"H.H. Loh, N.A. Kamaruddin, R. Zakaria, N. Sukor, Improvement of bone turnover markers and bone mineral density following treatment of primary aldosteronism. Minerva Endocrinol. 43(2), 117\u2013125 (2018). https:\/\/doi.org\/10.23736\/S0391-1977.16.02553-0","journal-title":"Minerva Endocrinol."},{"key":"2348_CR16","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.bone.2015.06.020","volume":"93","author":"A Hannemann","year":"2016","unstructured":"A. Hannemann, H. Wallaschofski, Reference intervals for serum concentrations of three bone turnover markers for men and women. Bone 93, 216 (2016). https:\/\/doi.org\/10.1016\/j.bone.2015.06.020","journal-title":"Bone"},{"issue":"10","key":"2348_CR17","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1515\/cclm-2012-0531","volume":"51","author":"A Morovat","year":"2013","unstructured":"A. Morovat, A. Catchpole, A. Meurisse, A. Carlisi, A.C. Bekaert, O. Rousselle, M. Paddon, T. James, E. Cavalier, IDS iSYS automated intact procollagen-1-N-terminus pro-peptide assay: method evaluation and reference intervals in adults and children. Clin. Chem. Lab. Med. 51(10), 2009\u20132018 (2013). https:\/\/doi.org\/10.1515\/cclm-2012-0531","journal-title":"Clin. Chem. Lab. Med."},{"key":"2348_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.cca.2016.06.036","volume":"467","author":"HA Morris","year":"2017","unstructured":"H.A. Morris, R. Eastell, N.R. Jorgensen, E. Cavalier, S. Vasikaran, S.A.P. Chubb, J.A. Kanis, C. Cooper, K. Makris, I.-I.W.G.F.S.O.B.M. Assays, Clinical usefulness of bone turnover marker concentrations in osteoporosis. Clin. Chim. Acta 467, 34\u201341 (2017). https:\/\/doi.org\/10.1016\/j.cca.2016.06.036","journal-title":"Clin. Chim. Acta"},{"key":"2348_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6823-13-11","volume":"13","author":"A Hannemann","year":"2013","unstructured":"A. Hannemann, N. Friedrich, C. Spielhagen, R. Rettig, T. Ittermann, M. Nauck, H. Wallaschofski, Reference intervals for serum osteocalcin concentrations in adult men and women from the study of health in Pomerania. BMC Endocr. Disord. 13, 11 (2013). https:\/\/doi.org\/10.1186\/1472-6823-13-11","journal-title":"BMC Endocr. Disord."},{"issue":"5","key":"2348_CR20","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"J.W. Funder, R.M. Carey, F. Mantero, M.H. Murad, M. Reincke, H. Shibata, M. Stowasser, W.F. Young Jr., The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101(5), 1889\u20131916 (2016). https:\/\/doi.org\/10.1210\/jc.2015-4061","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"2348_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1530\/EJE-11-0287","volume":"165","author":"MJ Betz","year":"2011","unstructured":"M.J. Betz, C. Degenhart, E. Fischer, A. Pallauf, V. Brand, U. Linsenmaier, F. Beuschlein, M. Bidlingmaier, M. Reincke, Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates. Eur. J. Endocrinol. 165(2), 301\u2013306 (2011). https:\/\/doi.org\/10.1530\/EJE-11-0287","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"2348_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/MED.0000000000000478","volume":"26","author":"S Athimulam","year":"2019","unstructured":"S. Athimulam, I. Bancos, Evaluation of bone health in patients with adrenal tumors. Curr. Opin. Endocrinol. Diabetes Obes. 26(3), 125\u2013132 (2019). https:\/\/doi.org\/10.1097\/MED.0000000000000478","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"1","key":"2348_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3803\/EnM.2018.33.1.1","volume":"33","author":"BJ Kim","year":"2018","unstructured":"B.J. Kim, S.H. Lee, J.M. Koh, Bone health in adrenal disorders. Endocrinol. Metab. 33(1), 1\u20138 (2018). https:\/\/doi.org\/10.3803\/EnM.2018.33.1.1","journal-title":"Endocrinol. Metab."},{"issue":"8","key":"2348_CR24","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1359\/jbmr.2001.16.8.1496","volume":"16","author":"S Beavan","year":"2001","unstructured":"S. Beavan, A. Horner, S. Bord, D. Ireland, J. Compston, Colocalization of glucocorticoid and mineralocorticoid receptors in human bone. J. Bone Min. Res. 16(8), 1496\u20131504 (2001). https:\/\/doi.org\/10.1359\/jbmr.2001.16.8.1496","journal-title":"J. Bone Min. Res."},{"key":"2348_CR25","doi-asserted-by":"publisher","unstructured":"L. Petramala, L. Zinnamosca, A. Settevendemmie, C. Marinelli, M. Nardi, A. Concistre, F. Corpaci, G. Tonnarini, G. De Toma, C. Letizia, Bone and mineral metabolism in patients with primary aldosteronism. Int. J. Endocrinol. 2014, 836529 (2014). https:\/\/doi.org\/10.1155\/2014\/836529","DOI":"10.1155\/2014\/836529"},{"issue":"6","key":"2348_CR26","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/jbmr.333","volume":"26","author":"M Gupta","year":"2011","unstructured":"M. Gupta, C.L. Cheung, Y.H. Hsu, S. Demissie, L.A. Cupples, D.P. Kiel, D. Karasik, Identification of homogeneous genetic architecture of multiple genetically correlated traits by block clustering of genome-wide associations. J. Bone Min. Res. 26(6), 1261\u20131271 (2011). https:\/\/doi.org\/10.1002\/jbmr.333","journal-title":"J. Bone Min. Res."},{"key":"2348_CR27","doi-asserted-by":"publisher","unstructured":"W. Arlt, K. Lang, A.J. Sitch, A.S. Dietz, Y. Rhayem, I. Bancos, A. Feuchtinger, V. Chortis, L.C. Gilligan, P. Ludwig, A. Riester, E. Asbach, B.A. Hughes, D.M. O\u2019Neil, M. Bidlingmaier, J.W. Tomlinson, Z.K. Hassan-Smith, D.A. Rees, C. Adolf, S. Hahner, M. Quinkler, T. Dekkers, J. Deinum, M. Biehl, B.G. Keevil, C.H.L. Shackleton, J.J. Deeks, A.K. Walch, F. Beuschlein, M. Reincke, Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism. JCI Insight 2(8), (2017). https:\/\/doi.org\/10.1172\/jci.insight.93136","DOI":"10.1172\/jci.insight.93136"},{"issue":"12","key":"2348_CR28","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1210\/jc.2018-00617","volume":"103","author":"C Adolf","year":"2018","unstructured":"C. Adolf, A. Kohler, A. Franke, K. Lang, A. Riester, A. Low, D.A. Heinrich, M. Bidlingmaier, M. Treitl, R. Ladurner, F. Beuschlein, W. Arlt, M. Reincke, Cortisol excess in patients with primary aldosteronism impacts left ventricular hypertrophy. J. Clin. Endocrinol. Metab. 103(12), 4543\u20134552 (2018). https:\/\/doi.org\/10.1210\/jc.2018-00617","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2348_CR29","doi-asserted-by":"publisher","unstructured":"J. Gerards, D.A. Heinrich, C. Adolf, C. Meisinger, W. Rathmann, L. Sturm, N. Nirschl, M. Bidlingmaier, F. Beuschlein, B. Thorand, A. Peters, M. Reincke, M. Roden, M. Quinkler, Impaired glucose metabolism in primary aldosteronism is associated with cortisol co-secretion. J. Clin. Endocrinol. Metab. (2019). https:\/\/doi.org\/10.1210\/jc.2019-00299","DOI":"10.1210\/jc.2019-00299"},{"issue":"6","key":"2348_CR30","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1080\/07315724.2018.1431161","volume":"37","author":"S Fatahi","year":"2018","unstructured":"S. Fatahi, N. Namazi, B. Larijani, L. Azadbakht, The association of dietary and urinary sodium with bone mineral density and risk of osteoporosis: a systematic review and meta-analysis. J. Am. Coll. Nutr. 37(6), 522\u2013532 (2018). https:\/\/doi.org\/10.1080\/07315724.2018.1431161","journal-title":"J. Am. Coll. Nutr."},{"issue":"3","key":"2348_CR31","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/ejcn.2014.284","volume":"69","author":"SM Park","year":"2015","unstructured":"S.M. Park, J.Y. Joung, Y.Y. Cho, S.Y. Sohn, K.Y. Hur, J.H. Kim, S.W. Kim, J.H. Chung, M.K. Lee, Y.K. Min, Effect of high dietary sodium on bone turnover markers and urinary calcium excretion in Korean postmenopausal women with low bone mass. Eur. J. Clin. Nutr. 69(3), 361\u2013366 (2015). https:\/\/doi.org\/10.1038\/ejcn.2014.284","journal-title":"Eur. J. Clin. Nutr."},{"issue":"1","key":"2348_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20896-y","volume":"8","author":"HY Dar","year":"2018","unstructured":"H.Y. Dar, A. Singh, P. Shukla, R. Anupam, R.K. Mondal, P.K. Mishra, R.K. Srivastava, High dietary salt intake correlates with modulated Th17-Treg cell balance resulting in enhanced bone loss and impaired bone-microarchitecture in male mice. Sci. Rep. 8(1), 2503 (2018). https:\/\/doi.org\/10.1038\/s41598-018-20896-y","journal-title":"Sci. Rep."},{"issue":"4","key":"2348_CR33","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00198-017-3904-8","volume":"28","author":"SJ Kwon","year":"2017","unstructured":"S.J. Kwon, Y.C. Ha, Y. Park, High dietary sodium intake is associated with low bone mass in postmenopausal women: Korea National Health and Nutrition Examination Survey, 2008-2011. Osteoporos. Int. 28(4), 1445\u20131452 (2017). https:\/\/doi.org\/10.1007\/s00198-017-3904-8","journal-title":"Osteoporos. Int."},{"issue":"11","key":"2348_CR34","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3390\/nu3110951","volume":"3","author":"JL Bedford","year":"2011","unstructured":"J.L. Bedford, S.I. Barr, Higher urinary sodium, a proxy for intake, is associated with increased calcium excretion and lower hip bone density in healthy young women with lower calcium intakes. Nutrients 3(11), 951\u2013961 (2011). https:\/\/doi.org\/10.3390\/nu3110951","journal-title":"Nutrients"},{"issue":"4","key":"2348_CR35","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ajcn\/62.4.740","volume":"62","author":"A Devine","year":"1995","unstructured":"A. Devine, R.A. Criddle, I.M. Dick, D.A. Kerr, R.L. Prince, A longitudinal study of the effect of sodium and calcium intakes on regional bone density in postmenopausal women. Am. J. Clin. Nutr. 62(4), 740\u2013745 (1995). https:\/\/doi.org\/10.1093\/ajcn\/62.4.740","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"2348_CR36","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s12020-015-0626-6","volume":"49","author":"T Remer","year":"2015","unstructured":"T. Remer, High salt intake: detrimental not only for blood pressure, but also for bone health? Endocrine 49(3), 580\u2013582 (2015). https:\/\/doi.org\/10.1007\/s12020-015-0626-6","journal-title":"Endocrine"},{"issue":"1-2","key":"2348_CR37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.steroids.2010.08.007","volume":"76","author":"M Sereg","year":"2011","unstructured":"M. Sereg, J. Toke, A. Patocs, I. Varga, P. Igaz, N. Szucs, J. Horanyi, P. Pusztai, S. Czirjak, E. Glaz, K. Racz, M. Toth, Diagnostic performance of salivary cortisol and serum osteocalcin measurements in patients with overt and subclinical Cushing\u2019s syndrome. Steroids 76(1-2), 38\u201342 (2011). https:\/\/doi.org\/10.1016\/j.steroids.2010.08.007","journal-title":"Steroids"},{"issue":"4","key":"2348_CR38","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00198-009-0978-y","volume":"21","author":"A Szappanos","year":"2010","unstructured":"A. Szappanos, J. Toke, D. Lippai, A. Patocs, P. Igaz, N. Szucs, L. Futo, E. Glaz, K. Racz, M. Toth, Bone turnover in patients with endogenous Cushing\u2019s syndrome before and after successful treatment. Osteoporos. Int. 21(4), 637\u2013645 (2010). https:\/\/doi.org\/10.1007\/s00198-009-0978-y","journal-title":"Osteoporos. Int."},{"issue":"10","key":"2348_CR39","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1210\/jcem.82.10.4282","volume":"82","author":"G Osella","year":"1997","unstructured":"G. Osella, M. Terzolo, G. Reimondo, A. Piovesan, A. Pia, A. Termine, P. Paccotti, A. Angeli, Serum markers of bone and collagen turnover in patients with Cushing\u2019s syndrome and in subjects with adrenal incidentalomas. J. Clin. Endocrinol. Metab. 82(10), 3303\u20133307 (1997). https:\/\/doi.org\/10.1210\/jcem.82.10.4282","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"2348_CR40","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/s0248-8663(02)00606-9","volume":"23","author":"S Bardet","year":"2002","unstructured":"S. Bardet, V. Rohmer, F. Boux de Casson, C. Coffin, N. Ronci, J.P. Sabatier, P. Lecomte, M. Audran, M. Henry-Amar, A. Tabarin, [Bone mineral density and biological markers of bone repair in patients with adrenal incidentaloma: effect of subclinical hypercortisolism]. Rev. Med Interne 23(6), 508\u2013517 (2002). https:\/\/doi.org\/10.1016\/s0248-8663(02)00606-9","journal-title":"Rev. Med Interne"},{"issue":"2","key":"2348_CR41","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1530\/eje.0.1380146","volume":"138","author":"A Sartorio","year":"1998","unstructured":"A. Sartorio, A. Conti, S. Ferrero, S. Giambona, T. Re, E. Passini, B. Ambrosi, Evaluation of markers of bone and collagen turnover in patients with active and preclinical Cushing\u2019s syndrome and in patients with adrenal incidentaloma. Eur. J. Endocrinol. 138(2), 146\u2013152 (1998). https:\/\/doi.org\/10.1530\/eje.0.1380146","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"2348_CR42","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1359\/jbmr.1998.13.2.297","volume":"13","author":"PD Ross","year":"1998","unstructured":"P.D. Ross, W. Knowlton, Rapid bone loss is associated with increased levels of biochemical markers. J. Bone Min. Res. 13(2), 297\u2013302 (1998). https:\/\/doi.org\/10.1359\/jbmr.1998.13.2.297","journal-title":"J. Bone Min. Res."},{"issue":"3","key":"2348_CR43","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1359\/JBMR.0301244","volume":"19","author":"P Gerdhem","year":"2004","unstructured":"P. Gerdhem, K.K. Ivaska, S.L. Alatalo, J.M. Halleen, J. Hellman, A. Isaksson, K. Pettersson, H.K. Vaananen, K. Akesson, K.J. Obrant, Biochemical markers of bone metabolism and prediction of fracture in elderly women. J. Bone Min. Res. 19(3), 386\u2013393 (2004). https:\/\/doi.org\/10.1359\/JBMR.0301244","journal-title":"J. Bone Min. Res."},{"issue":"4","key":"2348_CR44","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1210\/jcem.84.4.5606","volume":"84","author":"P Moghetti","year":"1999","unstructured":"P. Moghetti, R. Castello, N. Zamberlan, M. Rossini, D. Gatti, C. Negri, F. Tosi, M. Muggeo, S. Adami, Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist. J. Clin. Endocrinol. Metab. 84(4), 1250\u20131254 (1999). https:\/\/doi.org\/10.1210\/jcem.84.4.5606","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"2348_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jacc.2008.03.039","volume":"52","author":"LD Carbone","year":"2008","unstructured":"L.D. Carbone, J.D. Cross, S.H. Raza, A.J. Bush, R.J. Sepanski, S. Dhawan, B.Q. Khan, M. Gupta, K. Ahmad, R.N. Khouzam, D.A. Dishmon, J.P. Nesheiwat, M.A. Hajjar, W.A. Chishti, W. Nasser, M. Khan, C.R. Womack, T. Cho, A.R. Haskin, K.T. Weber, Fracture risk in men with congestive heart failure risk reduction with spironolactone. J. Am. Coll. Cardiol. 52(2), 135\u2013138 (2008). https:\/\/doi.org\/10.1016\/j.jacc.2008.03.039","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"2348_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-017-0888-0","volume":"19","author":"JI Barzilay","year":"2017","unstructured":"J.I. Barzilay, B.R. Davis, S.L. Pressel, A. Ghosh, R. Puttnam, K.L. Margolis, P.K. Whelton, The impact of antihypertensive medications on bone mineral density and fracture risk. Curr. Cardiol. Rep. 19(9), 76 (2017). https:\/\/doi.org\/10.1007\/s11886-017-0888-0","journal-title":"Curr. Cardiol. Rep."},{"issue":"9","key":"2348_CR47","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/0895-7061(95)00182-O","volume":"8","author":"E Rossi","year":"1995","unstructured":"E. Rossi, C. Sani, F. Perazzoli, M.C. Casoli, A. Negro, C. Dotti, Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. Am. J. Hypertens. 8(9), 884\u2013893 (1995). https:\/\/doi.org\/10.1016\/0895-7061(95)00182-O","journal-title":"Am. J. Hypertens."},{"issue":"7","key":"2348_CR48","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1161\/01.CIR.0000155621.10213.06","volume":"111","author":"VS Chhokar","year":"2005","unstructured":"V.S. Chhokar, Y. Sun, S.K. Bhattacharya, R.A. Ahokas, L.K. Myers, Z. Xing, R.A. Smith, I.C. Gerling, K.T. Weber, Hyperparathyroidism and the calcium paradox of aldosteronism. Circulation 111(7), 871\u2013878 (2005). https:\/\/doi.org\/10.1161\/01.CIR.0000155621.10213.06","journal-title":"Circulation"},{"issue":"2","key":"2348_CR49","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/07315724.2009.10719764","volume":"28","author":"RK Rude","year":"2009","unstructured":"R.K. Rude, F.R. Singer, H.E. Gruber, Skeletal and hormonal effects of magnesium deficiency. J. Am. Coll. Nutr. 28(2), 131\u2013141 (2009). https:\/\/doi.org\/10.1080\/07315724.2009.10719764","journal-title":"J. Am. Coll. Nutr."},{"issue":"1","key":"2348_CR50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4162\/nrp.2020.14.1.55","volume":"14","author":"J Ha","year":"2020","unstructured":"J. Ha, S.A. Kim, K. Lim, S. Shin, The association of potassium intake with bone mineral density and the prevalence of osteoporosis among older Korean adults. Nutr. Res Pract. 14(1), 55\u201361 (2020). https:\/\/doi.org\/10.4162\/nrp.2020.14.1.55","journal-title":"Nutr. Res Pract."},{"issue":"5","key":"2348_CR51","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00198-017-3908-4","volume":"28","author":"SH Kong","year":"2017","unstructured":"S.H. Kong, J.H. Kim, A.R. Hong, J.H. Lee, S.W. Kim, C.S. Shin, Dietary potassium intake is beneficial to bone health in a low calcium intake population: the Korean National Health and Nutrition Examination Survey (KNHANES) (2008-2011). Osteoporos. Int. 28(5), 1577\u20131585 (2017). https:\/\/doi.org\/10.1007\/s00198-017-3908-4","journal-title":"Osteoporos. Int."},{"issue":"4","key":"2348_CR52","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s11914-012-0115-2","volume":"10","author":"AO Aluoch","year":"2012","unstructured":"A.O. Aluoch, R. Jessee, H. Habal, M. Garcia-Rosell, R. Shah, G. Reed, L. Carbone, Heart failure as a risk factor for osteoporosis and fractures. Curr. Osteoporos. Rep. 10(4), 258\u2013269 (2012). https:\/\/doi.org\/10.1007\/s11914-012-0115-2","journal-title":"Curr. Osteoporos. Rep."},{"issue":"5","key":"2348_CR53","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/13697137.2019.1631789","volume":"22","author":"TJ de Villiers","year":"2019","unstructured":"T.J. de Villiers, C. Altomare, M. Particco, M. Gambacciani, Effects of ospemifene on bone in postmenopausal women. Climacteric 22(5), 442\u2013447 (2019). https:\/\/doi.org\/10.1080\/13697137.2019.1631789","journal-title":"Climacteric"},{"issue":"3","key":"2348_CR54","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.bbrc.2014.03.149","volume":"447","author":"T Fumoto","year":"2014","unstructured":"T. Fumoto, K.A. Ishii, M. Ito, S. Berger, G. Schutz, K. Ikeda, Mineralocorticoid receptor function in bone metabolism and its role in glucocorticoid-induced osteopenia. Biochem Biophys. Res Commun. 447(3), 407\u2013412 (2014). https:\/\/doi.org\/10.1016\/j.bbrc.2014.03.149","journal-title":"Biochem Biophys. Res Commun."}],"updated-by":[{"DOI":"10.1007\/s12020-021-02905-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T00:00:00Z","timestamp":1634947200000}}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02348-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-020-02348-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02348-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T11:15:32Z","timestamp":1634987732000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-020-02348-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,27]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["2348"],"URL":"https:\/\/doi.org\/10.1007\/s12020-020-02348-8","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12020-021-02905-9","asserted-by":"object"}]},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,27]]},"assertion":[{"value":"24 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12020-021-02905-9","URL":"https:\/\/doi.org\/10.1007\/s12020-021-02905-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The ethics committee of the University of Munich approved the protocols.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients gave written informed consent","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}